CLINICAL_TRIALS
trial_result
· 2012-06-20
Clinical Trial Update: Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension [Phase 2]
Summary
Phase 2 study of ambrisentan for liver function test rescue in pulmonary arterial hypertension has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2012-06-20